See more : Asiasec Properties Limited (0271.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Waters Corporation (WAT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Waters Corporation, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- Eusol Biotech Co.,Ltd. (6652.TWO) Income Statement Analysis – Financial Results
- Marble Financial Inc. (MRBLF) Income Statement Analysis – Financial Results
- Mene Inc. (MENE.V) Income Statement Analysis – Financial Results
- Khandwala Securities Limited (KHANDSE.BO) Income Statement Analysis – Financial Results
- DTE Energy Company JR SUB DB 2017 E (DTW) Income Statement Analysis – Financial Results
Waters Corporation (WAT)
About Waters Corporation
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.96B | 2.97B | 2.79B | 2.37B | 2.41B | 2.42B | 2.31B | 2.17B | 2.04B | 1.99B | 1.90B | 1.84B | 1.85B | 1.64B | 1.50B | 1.58B | 1.47B | 1.28B | 1.16B | 1.10B | 958.21M | 889.97M | 859.21M | 795.07M | 704.40M | 618.80M | 465.50M | 391.10M | 333.00M |
| Cost of Revenue | 1.20B | 1.25B | 1.16B | 1.01B | 1.01B | 992.56M | 947.07M | 891.45M | 842.67M | 824.91M | 783.46M | 737.61M | 730.49M | 653.30M | 594.88M | 661.27M | 631.12M | 536.19M | 478.36M | 454.81M | 397.85M | 373.47M | 311.23M | 265.90M | 235.60M | 213.40M | 158.70M | 133.60M | 109.70M |
| Gross Profit | 1.76B | 1.72B | 1.63B | 1.36B | 1.40B | 1.43B | 1.36B | 1.28B | 1.20B | 1.16B | 1.12B | 1.11B | 1.12B | 990.07M | 903.82M | 913.86M | 841.93M | 744.04M | 679.88M | 649.73M | 560.36M | 516.50M | 547.98M | 529.17M | 468.80M | 405.40M | 306.80M | 257.50M | 223.30M |
| Gross Profit Ratio | 59.57% | 58.00% | 58.49% | 57.44% | 58.00% | 58.98% | 58.99% | 58.87% | 58.74% | 58.53% | 58.86% | 59.99% | 60.54% | 60.25% | 60.31% | 58.02% | 57.16% | 58.12% | 58.70% | 58.82% | 58.48% | 58.04% | 63.78% | 66.56% | 66.55% | 65.51% | 65.91% | 65.84% | 67.06% |
| Research & Development | 174.95M | 176.19M | 168.36M | 140.78M | 142.96M | 143.40M | 132.59M | 125.19M | 118.55M | 107.73M | 100.54M | 96.00M | 92.35M | 84.27M | 77.15M | 81.59M | 80.65M | 77.31M | 66.91M | 65.24M | 59.24M | 51.92M | 46.60M | 42.51M | 36.10M | 34.40M | 80.80M | 20.90M | 17.70M |
| General & Administrative | 690.34M | 651.03M | 619.97M | 547.70M | 528.79M | 529.90M | 538.70M | 502.03M | 484.75M | 500.71M | 481.97M | 464.27M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 7.00M | 7.00M | 7.00M | 6.00M | 6.00M | 7.00M | 6.00M | 11.00M | 11.00M | 12.00M | 11.00M | 13.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 736.01M | 658.03M | 626.97M | 553.70M | 534.79M | 536.90M | 544.70M | 513.03M | 495.75M | 512.71M | 492.97M | 477.27M | 490.01M | 445.46M | 421.40M | 426.70M | 403.70M | 357.66M | 321.69M | 300.15M | 264.25M | 246.82M | 269.71M | 246.39M | 226.60M | 206.20M | 167.30M | 148.50M | 132.70M |
| Other Expenses | 32.56M | 6.37M | 7.14M | 10.59M | 9.69M | -47.79M | 6.74M | 9.89M | 10.12M | 10.63M | -1.58M | 13.83M | 9.73M | 10.41M | 10.66M | 15.82M | 8.70M | 5.44M | 8.13M | -466.00K | 16.77M | 13.95M | 82.14M | 29.44M | 29.60M | 28.40M | 21.10M | 17.80M | 16.50M |
| Operating Expenses | 943.52M | 840.58M | 802.47M | 705.06M | 687.44M | 688.02M | 684.04M | 648.11M | 624.42M | 631.07M | 603.42M | 587.10M | 592.09M | 540.14M | 509.22M | 524.10M | 493.05M | 440.41M | 396.73M | 364.93M | 340.27M | 312.68M | 398.45M | 318.34M | 292.30M | 269.00M | 269.20M | 187.20M | 166.90M |
| Cost & Expenses | 2.14B | 2.09B | 1.96B | 1.71B | 1.70B | 1.68B | 1.63B | 1.54B | 1.47B | 1.46B | 1.39B | 1.32B | 1.32B | 1.19B | 1.10B | 1.19B | 1.12B | 976.59M | 875.08M | 819.73M | 738.12M | 686.15M | 709.68M | 584.24M | 527.90M | 482.40M | 427.90M | 320.80M | 276.60M |
| Interest Income | 16.62M | 11.02M | 12.22M | 16.27M | 22.06M | 38.81M | 36.08M | 20.69M | 10.71M | 7.02M | 4.39M | 4.21M | 2.62M | 1.86M | 3.04M | 0.00 | 0.00 | 0.00 | 19.26M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 98.86M | 37.78M | 32.72M | 32.80M | 26.63M | 9.83M | 20.76M | 24.23M | 25.53M | 27.17M | 25.66M | 23.87M | 19.35M | 12.07M | 7.95M | 17.56M | 25.69M | 32.19M | 8.59M | 0.00 | 0.00 | 5.51M | 2.10M | 10.64M | 9.00M | 34.90M | 30.10M | 39.20M | 39.20M |
| Depreciation & Amortization | 165.91M | 130.42M | 131.68M | 125.36M | 105.30M | 108.41M | 106.00M | 96.45M | 10.12M | 10.63M | 9.92M | 13.83M | 9.73M | 10.41M | 10.66M | 65.27M | 53.32M | 46.16M | 43.69M | 41.93M | 33.85M | 37.19M | 33.95M | 29.44M | 29.60M | 28.40M | 21.10M | 17.80M | 16.50M |
| EBITDA | 1.00B | 1.01B | 958.43M | 777.97M | 822.09M | 799.64M | 783.97M | 725.01M | 668.23M | 638.31M | 597.04M | 584.53M | 597.61M | 514.35M | 454.91M | 475.98M | 402.20M | 360.78M | 326.84M | 337.67M | 253.94M | 241.01M | 183.48M | 240.26M | 206.10M | 164.80M | 58.70M | 88.10M | 72.90M |
| EBITDA Ratio | 33.86% | 34.18% | 35.03% | 33.28% | 33.66% | 33.06% | 33.95% | 29.42% | 28.66% | 27.35% | 27.61% | 28.90% | 29.08% | 28.01% | 27.04% | 29.30% | 27.30% | 28.44% | 28.76% | 29.19% | 27.93% | 29.75% | 30.91% | 30.22% | 29.26% | 29.30% | 16.15% | 28.79% | 24.53% |
| Operating Income | 817.68M | 873.40M | 821.71M | 645.49M | 708.46M | 739.77M | 661.86M | 624.34M | 567.45M | 517.91M | 517.34M | 511.49M | 528.60M | 449.93M | 394.60M | 389.75M | 348.88M | 295.15M | 283.16M | 284.86M | 219.17M | 196.41M | 149.53M | 210.83M | 176.50M | 136.40M | 37.60M | 70.30M | 56.40M |
| Operating Income Ratio | 27.66% | 29.39% | 29.50% | 27.29% | 29.44% | 30.57% | 28.66% | 28.81% | 27.78% | 26.03% | 27.17% | 27.74% | 28.55% | 27.38% | 26.33% | 24.74% | 23.68% | 23.05% | 24.45% | 25.79% | 22.87% | 22.07% | 17.40% | 26.52% | 25.06% | 22.04% | 8.08% | 17.97% | 16.94% |
| Total Other Income/Expenses | -81.43M | -35.55M | -15.51M | -34.58M | -30.22M | -57.63M | -21.10M | -24.93M | -25.53M | -27.17M | -27.24M | -23.87M | -19.35M | -12.07M | -7.95M | -17.56M | -25.69M | -36.78M | -8.59M | 813.00K | 4.51M | -1.00M | -2.10M | 135.00K | -9.00M | -34.90M | -30.10M | -39.20M | -39.20M |
| Income Before Tax | 736.24M | 837.85M | 806.19M | 610.91M | 678.24M | 682.15M | 641.10M | 600.11M | 541.92M | 490.74M | 490.11M | 487.63M | 509.25M | 437.86M | 386.65M | 372.19M | 323.19M | 262.96M | 274.56M | 285.67M | 223.69M | 195.41M | 147.43M | 210.96M | 167.50M | 101.50M | 7.50M | 31.10M | 17.20M |
| Income Before Tax Ratio | 24.90% | 28.19% | 28.94% | 25.83% | 28.18% | 28.19% | 27.76% | 27.69% | 26.53% | 24.67% | 25.74% | 26.45% | 27.51% | 26.64% | 25.80% | 23.63% | 21.94% | 20.54% | 23.71% | 25.86% | 23.34% | 21.96% | 17.16% | 26.53% | 23.78% | 16.40% | 1.61% | 7.95% | 5.17% |
| Income Tax Expense | 94.01M | 130.09M | 113.35M | 89.34M | 86.04M | 88.35M | 620.79M | 78.61M | 72.87M | 59.12M | 40.10M | 26.18M | 76.28M | 56.10M | 63.34M | 49.71M | 55.12M | 40.76M | 72.59M | 61.62M | 52.80M | 43.19M | 32.88M | 54.85M | 45.20M | 27.10M | 15.80M | 11.20M | 3.10M |
| Net Income | 642.23M | 707.76M | 692.84M | 521.57M | 592.20M | 593.79M | 20.31M | 521.50M | 469.05M | 431.62M | 450.00M | 461.44M | 432.97M | 381.76M | 323.31M | 322.48M | 268.07M | 222.20M | 201.98M | 224.05M | 170.89M | 147.71M | 114.54M | 145.34M | 122.30M | 74.40M | -8.30M | -2.40M | 2.00M |
| Net Income Ratio | 21.72% | 23.81% | 24.87% | 22.05% | 24.61% | 24.54% | 0.88% | 24.06% | 22.97% | 21.70% | 23.63% | 25.03% | 23.39% | 23.23% | 21.57% | 20.47% | 18.20% | 17.36% | 17.44% | 20.28% | 17.83% | 16.60% | 13.33% | 18.28% | 17.36% | 12.02% | -1.78% | -0.61% | 0.60% |
| EPS | 10.87 | 11.80 | 11.25 | 8.40 | 8.76 | 7.71 | 0.25 | 6.46 | 5.70 | 5.12 | 5.27 | 5.25 | 4.77 | 4.13 | 3.37 | 3.25 | 2.67 | 2.16 | 1.77 | 1.87 | 1.39 | 1.13 | 0.88 | 1.14 | 0.99 | 0.61 | -0.07 | -0.02 | 0.01 |
| EPS Diluted | 10.84 | 11.73 | 11.17 | 8.36 | 8.69 | 7.65 | 0.25 | 6.41 | 5.65 | 5.07 | 5.20 | 5.19 | 4.69 | 4.06 | 3.34 | 3.21 | 2.62 | 2.13 | 1.74 | 1.82 | 1.34 | 1.09 | 0.83 | 1.06 | 0.92 | 0.57 | -0.07 | -0.02 | 0.01 |
| Weighted Avg Shares Out | 59.08M | 59.99M | 61.58M | 62.09M | 67.63M | 76.99M | 79.79M | 80.79M | 82.34M | 84.36M | 85.43M | 87.84M | 90.83M | 92.39M | 95.80M | 99.20M | 100.50M | 102.69M | 114.02M | 119.64M | 123.19M | 130.49M | 130.56M | 127.57M | 123.01M | 119.72M | 116.51M | 120.00M | 110.00M |
| Weighted Avg Shares Out (Dil) | 59.27M | 60.33M | 62.03M | 62.41M | 68.17M | 77.62M | 80.60M | 81.42M | 83.09M | 85.15M | 86.55M | 88.98M | 92.33M | 94.06M | 96.86M | 100.56M | 102.51M | 104.24M | 115.95M | 123.07M | 127.58M | 135.76M | 137.51M | 136.74M | 132.63M | 119.72M | 116.51M | 120.00M | 110.00M |
Elf Beauty says short-seller Muddy Waters' allegations are 'without merit'
Elf Beauty said on Thursday allegations by short-seller Muddy Waters about the beauty company overstating its revenue and inventory numbers were "without merit".
Muddy Waters CEO Carson Block Says He's Shorting Elf Beauty
Muddy Waters' Carson Block says he's shorting Elf Beauty Inc. as he thinks the cosmetics brand has overstated revenue in recent quarters and that a build up in the beauty company's inventory was due to lackluster sales. Elf Beauty's shares...
Elf Beauty stock slides after Muddy Waters says it has shorted its shares
Muddy Waters has taken a short position in cosmetics company Elf Beauty , the hedge fund's chief executive Carson Block said at the Sohn conference in London on Wednesday.
Muddy Waters' Carson Block Bets Against E.L.F. Beauty: Short Seller Says Retailer's Financials Show 'Major Red Flag'
Muddy Waters Research founder Carson Block announced a new short position in E.l.f. Beauty, Inc ELF at the Sohn conference on Wednesday, which sent shares of the cosmetics company tumbling.
Waters Corporation to Present at the Evercore 2024 HealthCONx Conference
MILFORD, Mass. , Nov. 20, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D.
Why Muddy Waters' CIO Carson Block is skeptical of e.l.f. Beauty
Carson Block, founder and CIO of Muddy Waters Research, joins CNBC's 'The Exchange' to discuss why his firm is shorting e.l.f. Beauty, why he believes the company may be lying about some of its data, and more.
Waters Corporation Opens State-of-the-Art Precision Manufacturing Facility in Longbridge, UK
News summary: Newly built 45,000 sq ft facility houses engineering and skilled manufacturing employees at Longbridge Business Park, a specialized hub for science and technology. Waters triples manufacturing footprint while increasing precision machining and metrology capacity to support future growth.
Confluence's Revolution solution recognized as Best Buy-side Risk Management Initiative by Waters Technology
PITTSBURGH--(BUSINESS WIRE)--Confluence Technologies, Inc. (“Confluence”), a global technology solutions provider for regulatory, analytics, and investor communications solutions for the investment management industry, proudly announced that its Revolution solution for multi-asset performance, attribution and risk analytics, has been named Best Buy-side...
Waters New Software Delivers Lab-Centric Business Intelligence and Enables Confident Audit-Readiness
News Summary: waters_connect™ Data Intelligence software provides laboratories with comprehensive business intelligence on their chromatographic data throughout the product development lifecycle, enabling real-time audit readiness and query response, while reducing time spent on audit preparation. Cloud-based software proactively provides visibility...
Waters Stock Gains on Earnings & Sales Beat in Q3, Raised View
WAT's third-quarter 2024 results show growth in the pharma and industrial sectors. A dip in China sales creates headwinds.
Source: https://incomestatements.info
Category: Stock Reports
How did Waters Corporation’s EPS change in 2023?
On a GAAP basis, EPS for fiscal year 2023 was $10.84, compared to $11.73 for fiscal year 2022. On a non-GAAP basis, EPS was $11.75, compared to $12.02 in fiscal year 2022. This includes a headwind of approximately 3% due to unfavorable foreign exchange and a 1% dilution from the Wyatt acquisition.
What were Waters Corporation’s revenue and profits in 2023?
For fiscal year 2023, the Company’s sales were $2,956 million, a decrease of 0.5% as reported, compared to sales of $2,972 million for fiscal year 2022. Currency translation decreased sales by approximately 1%, while the impact of acquisitions increased sales by 2.5%.
How did the Wyatt acquisition affect Waters’ 2023 financials?
In 2023, we completed the largest acquisition in Waters history with Wyatt Technology LLC, which contributed 2.5% to our revenues.